Physician profile
William Mackey
NPI 1952384000
$906.43
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2021: $313 · 2022: $177.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $220.89 | 2019-2021 | |
| Veryan Medical Incorporated | $126.89 | 2021 | |
| Terumo Medical Corporation | $118.81 | 2019 | |
| W. L. Gore & Associates, INC. | $106.51 | 2022 | |
| Cardiovascular Systems INC. | $71.21 | 2019 | |
| Shockwave Medical, INC | $70.91 | 2022 | |
| Ekos Corporation | $62.27 | 2019 | |
| Endologix LLC | $60.43 | 2021 | |
| Ethicon US, LLC | $37.78 | 2019 | |
| Smith+Nephew, INC. | $30.73 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.